FIELD: medicine.
SUBSTANCE: present invention concerns area of medical products, in particular, to the pressed tablet including valsartan as active substance and from 50% to 65% of microcrystallic cellulose in recalculation on a process weight of components of a kernel of this pressed tablet.
EFFECT: valsartan bioavailability augmentation.
5 cl, 9 tbl, 12 ex
Authors
Dates
2009-07-20—Published
2005-08-01—Filed